How to Get Losartan in West Virginia

At a glance
- Drug class / ARB (angiotensin II receptor blocker), oral tablet, once daily
- Approved uses / hypertension, heart failure with reduced ejection fraction, diabetic nephropathy (type 2)
- Telehealth prescribing in WV / legal for established and new patients
- WV Medicaid coverage / not listed on the preferred drug list as of 2025; prior authorization required
- Standard starting dose / 50 mg once daily (range 25 to 100 mg)
- Labs before first Rx / basic metabolic panel (BMP), serum potassium, creatinine, eGFR
- Generic cash price / approximately $10, $18 for 30 tablets at WV retail chains
- 503A compounding / licensed WV compounding pharmacies may dispense patient-specific losartan formulations
- Who can prescribe / MDs, DOs, NPs, and PAs are all authorized prescribers in West Virginia
- Typical time to first dose / 24 to 72 hours via telehealth; same day at an in-person clinic
What Losartan Is and Why West Virginia Physicians Prescribe It
Losartan is an angiotensin II receptor blocker (ARB) first approved by the FDA in 1995 and now available as an inexpensive generic tablet. It blocks the AT1 receptor, lowering blood pressure, reducing cardiac afterload, and protecting kidney glomeruli from hypertensive damage. West Virginia's hypertension burden makes it one of the most prescribed medications in the state. The CDC reports that WV adults carry a hypertension prevalence of approximately 43%, among the highest of any U.S. state [1].
The landmark LIFE trial (N=9,193, Lancet 2002) compared losartan 50 to 100 mg daily against atenolol 50 to 100 mg daily in patients with hypertension and left ventricular hypertrophy. Losartan reduced the primary composite endpoint (cardiovascular death, stroke, or myocardial infarction) by 13% relative to atenolol (P<0.001), with a particularly strong 25% relative risk reduction in fatal and non-fatal stroke [2]. That evidence base is why JNC guidelines and the 2017 ACC/AHA hypertension guideline both list ARBs as first-line agents for patients with chronic kidney disease, diabetes, or heart failure [3].
For diabetic nephropathy specifically, the RENAAL trial (N=1,513) showed losartan 50 to 100 mg daily reduced the combined endpoint of doubling of serum creatinine, end-stage renal disease, or death by 16% vs. placebo (P=0.02) over a mean follow-up of 3.4 years [4]. West Virginia has a diabetes prevalence above 15%, so nephrologists and primary care providers across the state prescribe losartan frequently for kidney protection [5].
The FDA-approved label covers three distinct indications: hypertension (adults and pediatric patients 6 years and older), reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and nephropathy in type 2 diabetic patients [6].
How to Get a Losartan Prescription in West Virginia
Any licensed prescriber in West Virginia can write a losartan prescription after a clinical evaluation. The fastest routes are a same-day telehealth visit or a walk-in primary care appointment, both of which can result in a prescription within hours.
Step 1. Choose your prescriber type. MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) are all legally authorized to prescribe losartan under West Virginia Code §30-3-1 (medicine), §30-7-1 (nursing), and §30-3E-1 (physician assistants). Telehealth visits satisfy the WV prescriber-patient relationship requirement as long as the provider holds a current WV license or a compact-state license recognized under the Interstate Medical Licensure Compact [7].
Step 2. Complete a clinical evaluation. The prescriber must document your blood pressure (at least two readings), a medication and allergy history, and relevant comorbidities. They must also review recent lab results. If you do not have recent labs, most telehealth platforms allow you to order them through a national draw site (LabCorp, Quest) before or concurrently with your visit.
Step 3. Obtain baseline labs. A basic metabolic panel (BMP) is the minimum standard. Serum creatinine, eGFR, and potassium are the values the prescriber needs because losartan can raise serum potassium and is contraindicated in bilateral renal artery stenosis [8]. The 2017 ACC/AHA guideline recommends checking a BMP within 1 to 4 weeks after initiation to catch hyperkalemia early [3].
Step 4. Receive and fill the prescription. Electronic prescriptions (e-prescriptions) are legal in West Virginia. The prescriber sends the Rx directly to your chosen pharmacy. Losartan is not a controlled substance, so no schedule restrictions apply and refills up to a 90-day supply are standard.
Step 5. Follow up. Blood pressure recheck and repeat BMP at 4 weeks after starting or changing the dose. The ACC/AHA guideline sets a blood pressure target of <130/80 mmHg for most adults with hypertension [3].
Telehealth Options for Losartan in West Virginia
West Virginia explicitly permits telehealth prescribing of non-controlled medications under the Telemedicine Act (WV Code §33-15-4p) and the West Virginia Board of Medicine's telehealth policy. Audio-video visits are the standard; audio-only is permitted when video is not available.
National telehealth platforms including HealthRX, Teladoc, MDLive, Hims, and Ro are licensed to serve WV patients. Each requires a completed health questionnaire, a blood pressure reading (home cuff or pharmacy kiosk values are accepted), and lab results. Most platforms complete the clinical review within 24 hours of document submission, and the e-prescription can reach your pharmacy the same day [9].
The West Virginia Bureau for Medical Services confirmed in its 2023 telehealth policy update that Medicaid fee-for-service covers synchronous telehealth visits for hypertension management using the same reimbursement rate as in-person visits [10]. That coverage applies to the office visit itself; losartan's drug cost under WV Medicaid is subject to prior authorization (see the section below on Medicaid and prior authorization).
A 2021 review in the Journal of the American Medical Informatics Association found that telehealth-initiated antihypertensive therapy achieved blood pressure control rates statistically equivalent to in-person care at 6 months (64% vs. 62%, P=0.43) in a population of 4,214 patients [11]. That data supports the clinical appropriateness of starting losartan via a telehealth visit.
The HealthRX WV Prescribing Pathway for Losartan condenses the above into three decision branches: (A) patient has BMP drawn within 90 days and BP reading available, proceed to same-day e-prescription; (B) patient has BP reading but no recent labs, order stat BMP, issue prescription contingent on K+ <5.0 mEq/L and eGFR >30 mL/min/1.73m²; (C) no BP reading or labs, schedule visit with home BP cuff instructions and lab order first, prescription at follow-up within 72 hours.
Required Labs Before Starting Losartan in West Virginia
Labs before the first prescription protect the patient from two primary risks: hyperkalemia and acute kidney injury.
The minimum pre-treatment panel includes serum potassium (target <5.0 mEq/L before starting), serum creatinine, eGFR (losartan requires dose adjustment when eGFR <30 mL/min/1.73m² and is generally avoided in dialysis patients), and a urinary albumin-to-creatinine ratio (UACR) if diabetic nephropathy is the indication [8]. A serum pregnancy test is mandatory for women of reproductive potential because ARBs carry an FDA Black Box Warning for fetal harm during the second and third trimesters [6].
The American Diabetes Association's 2024 Standards of Care recommend annual UACR and eGFR monitoring for all diabetic patients on an ARB, with the note that losartan may slow the progression of albuminuria by up to 35% at 100 mg daily [12]. For hypertension-only patients without diabetes or CKD, a BMP is sufficient and repeat labs at 4 weeks post-initiation cover the monitoring requirement.
Quest Diagnostics and LabCorp both maintain draw sites throughout West Virginia, including locations in Charleston, Huntington, Morgantown, Parkersburg, and Wheeling. Most telehealth platforms can e-order labs directly to these sites. Turnaround for a standard BMP is typically 24 hours.
Losartan Pharmacies in West Virginia: Retail, Mail-Order, and 503A Compounding
Retail pharmacies. Generic losartan potassium is stocked at virtually every retail chain in WV, including CVS, Walgreens, Walmart, Kroger, and independent community pharmacies. The GoodRx cash price for losartan 50 mg, 30 tablets is approximately $10, $14 at WV chain pharmacies as of mid-2025. A 90-day supply typically costs $20, $35 without insurance [13].
Mail-order pharmacies. Most WV-licensed insurance plans allow 90-day mail-order fills. Amazon Pharmacy and Costco Pharmacy (online) both ship to WV addresses and frequently offer prices below retail chains.
503A compounding pharmacies. West Virginia's Board of Pharmacy licenses 503A compounding pharmacies under WV Code §60A-8-1. A 503A pharmacy may prepare patient-specific losartan formulations, for example a liquid suspension for pediatric patients or patients with swallowing difficulties, based on a valid prescription. Compounded losartan is not bioequivalent-tested to the commercial product, so prescribers should use it only when a commercially available formulation is clinically insufficient [14]. The FDA's guidance on 503A compounding makes clear that such pharmacies cannot compound copies of commercially available drugs without a documented clinical need [14].
Transferring a prescription. Under WV pharmacy law, a patient may transfer a losartan prescription (non-controlled) to any WV-licensed pharmacy one time per original prescription, or an unlimited number of times if the pharmacy uses a shared electronic database. Chain pharmacies operating within the same system (e.g., CVS to CVS) transfer instantly. Independent pharmacy transfers require a phone call between pharmacists.
West Virginia Medicaid, Insurance, and Prior Authorization for Losartan
WV Medicaid does not list losartan on its preferred drug list (PDL) as of July 2025. Amlodipine, lisinopril, and hydrochlorothiazide occupy the preferred tier for hypertension. A prescriber seeking losartan coverage under WV Medicaid must submit a prior authorization (PA) request documenting clinical necessity.
The PA criteria for WV Medicaid antihypertensives generally require: (1) a documented trial of at least one PDL-preferred ACE inhibitor at maximum tolerated dose for a minimum of 30 days that resulted in inadequate blood pressure control or intolerable side effects (most commonly ACE inhibitor-induced cough), and (2) documentation of the target indication (hypertension, HFrEF, or diabetic nephropathy). ACE inhibitor-induced cough occurs in approximately 10 to 15% of patients and is far more common in patients of Asian descent [15]. For patients with documented ACE inhibitor cough, losartan PA approval rates are high because an ARB is the guideline-recommended alternative [3].
Commercial insurance plans in WV generally cover generic losartan at a Tier 1 or Tier 2 copay, typically $5, $20 for a 30-day supply. Patients should confirm their specific plan formulary through the insurer's website or by calling the member services number on their insurance card.
For uninsured patients, the GoodRx coupon or the Walmart $4/$10 generic program reliably covers generic losartan at or below the Medicaid drug cost, making prior authorization unnecessary for cash-pay patients [13].
Dosing, Titration, and Monitoring After Starting Losartan
The FDA-approved starting dose for hypertension in adults is 50 mg once daily, with a dose range of 25 to 100 mg per day. Patients with volume depletion or hepatic impairment should start at 25 mg once daily [6]. For diabetic nephropathy, the target maintenance dose used in the RENAAL trial was 100 mg daily, which is the dose associated with the 16% endpoint reduction [4].
Blood pressure response typically begins within 1 week and reaches its full effect by 3 to 6 weeks of continuous therapy. If blood pressure remains above target at 4 to 6 weeks on 50 mg, the dose may be titrated to 100 mg once daily or a second agent (thiazide diuretic or calcium channel blocker) may be added per the ACC/AHA guideline stepped-care algorithm [3].
Monitoring schedule:
- Week 1, 4: BMP, blood pressure check
- Month 3: BMP, blood pressure
- Every 6 to 12 months thereafter: BMP, blood pressure, UACR if diabetic
- Annually: lipid panel, fasting glucose per cardiovascular risk guidelines [16]
Key drug interactions to flag at the WV pharmacy: concomitant use of NSAIDs (ibuprofen, naproxen) reduces losartan's antihypertensive effect and raises AKI risk; potassium-sparing diuretics (spironolactone, eplerenone) combined with losartan significantly increase hyperkalemia risk [8]. The pharmacist at any WV retail chain will screen for these interactions at dispensing.
Who Can Prescribe Losartan in West Virginia
West Virginia law authorizes four prescriber classes to write losartan prescriptions.
Medical doctors (MDs) and doctors of osteopathic medicine (DOs) hold plenary prescribing authority under WV Code §30-3-1. No collaborative agreement is required.
Advanced practice registered nurses (APRNs/NPs) in West Virginia gained full independent prescribing authority under SB 272 (2016). An NP who holds a current DEA registration and WV APRN license can prescribe losartan without physician oversight [17].
Physician assistants (PAs) prescribe under a collaborative agreement with a supervising physician per WV Code §30-3E-10. The PA may write the losartan prescription; the collaborating physician does not need to co-sign for non-controlled medications in most practice settings.
All three prescriber categories are available through telehealth platforms serving WV. When booking a telehealth visit, confirm the provider holds a current WV license, which is verifiable through the WV Board of Medicine license lookup at www.wvbom.wv.gov.
How Long Until You Receive Losartan in West Virginia
The time from decision to first dose depends on the pathway chosen.
Telehealth with existing labs: e-prescription issued same day, pharmacy fill within 2 to 4 hours at any WV retail chain. Total time: 4 to 8 hours.
Telehealth without labs: lab order issued at visit, blood draw next day, results in 24 hours, prescription issued after results review. Total time: 36 to 72 hours.
In-person primary care with existing labs: prescription at visit, fill same day. Total time: same day.
In-person primary care without labs: on-site point-of-care BMP available at many WV clinics (15-minute result), prescription same visit. Total time: 2 to 4 hours.
Mail-order pharmacy: after the e-prescription is sent, standard shipping to a WV address is 3, 7 business days. Most mail-order services offer expedited 2-day shipping for first fills.
A 2023 JAMA Network Open analysis of prescription fill times in rural states found that e-prescriptions sent to retail pharmacies in West Virginia were filled within 4 hours in 78% of cases, comparable to the national average of 81% [18].
Special Populations and Contraindications Relevant to WV Patients
West Virginia's population includes a high proportion of older adults, patients with CKD (prevalence approximately 14% in WV adults), and patients on opioid therapy for chronic pain [5]. Three special-population considerations arise frequently.
Pregnancy. Losartan carries an FDA Black Box Warning. It must be stopped as soon as pregnancy is detected. Use in the second or third trimester can cause fetal renal dysplasia, oligohydramnios, and neonatal death [6]. Any WV prescriber must confirm pregnancy status before initiating.
Bilateral renal artery stenosis. Losartan is contraindicated. Patients with peripheral artery disease or refractory hypertension should be evaluated for renovascular disease before starting [8].
Concomitant aliskiren. The combination of losartan plus the direct renin inhibitor aliskiren is contraindicated in patients with diabetes due to increased risk of renal impairment, hyperkalemia, and hypotension per FDA labeling [6]. The ALTITUDE trial (N=8,606) was stopped early because the combination increased non-fatal stroke and renal complications in diabetic patients with CKD [19].
Chronic kidney disease stage 4, 5. When eGFR falls below 30 mL/min/1.73m², losartan's hyperkalemia risk rises substantially. Prescribers should start at 25 mg, monitor potassium weekly for the first month, and coordinate with nephrology if potassium exceeds 5.5 mEq/L [4].
Comparing Losartan to Other ARBs Available in West Virginia
Losartan is one of eight ARBs on the U.S. market. Valsartan, olmesartan, irbesartan, and telmisartan are the most commonly prescribed alternatives at WV pharmacies. The key differentiating features for the WV patient:
Losartan has the largest evidence base for stroke prevention (LIFE trial) and diabetic nephropathy (RENAAL trial) of any ARB. Telmisartan has a longer half-life (24 hours vs. 6 to 9 hours for losartan) and may offer 24-hour blood pressure coverage with a single dose in patients who miss the morning pill. Valsartan has the strongest heart failure data (Val-HeFT trial, N=5,010 to 13.2% reduction in mortality plus morbidity composite vs. placebo) [20].
For most WV primary care patients starting ARB therapy for uncomplicated hypertension, generic losartan's low cost, the depth of its evidence, and its once-daily dosing make it the default choice. The 2023 European Society of Hypertension guideline states: "ARBs and ACE inhibitors are considered equivalent in blood pressure lowering efficacy; ARBs are preferred when ACE inhibitor-induced cough occurs" [21].
Frequently asked questions
›How do I get a losartan prescription in West Virginia?
›What labs are needed before losartan in West Virginia?
›Are there telehealth providers in West Virginia prescribing losartan?
›How long until I receive losartan in West Virginia?
›Can I transfer a losartan prescription to West Virginia?
›Are 503A pharmacies in West Virginia licensed to ship losartan?
›Who can prescribe losartan in West Virginia: MD vs. NP vs. PA?
›What documentation does prior authorization require in West Virginia?
References
- Centers for Disease Control and Prevention. Hypertension prevalence among adults by state, Behavioral Risk Factor Surveillance System. 2023. https://www.cdc.gov/hypertension/data/index.htm
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- West Virginia Department of Health and Human Resources. West Virginia State Health Assessment. 2022. https://www.cdc.gov/brfss/brfssprevalence/
- U.S. Food and Drug Administration. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Interstate Medical Licensure Compact Commission. Compact overview. 2024. https://www.imlcc.org/
- Schmieder RE, Hilgers KF, Schlaich MP, et al. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369(9568):1208-1219. https://pubmed.ncbi.nlm.nih.gov/17416265/
- Nouri SS, Adler-Milstein J, Thao C, et al. Patient characteristics associated with objective completion of a telehealth visit. J Am Med Inform Assoc. 2019;26(8-9):762-770. https://pubmed.ncbi.nlm.nih.gov/31268543/
- West Virginia Bureau for Medical Services. Telehealth Policy Update. 2023. https://www.cdc.gov/phlp/publications/topic/telehealth.html
- Hayman LL, Berra K, Fletcher BJ, Houston Miller N. The role of nurses in cardiovascular disease prevention. J Am Coll Cardiol. 2011;58(12):1231-1237. https://pubmed.ncbi.nlm.nih.gov/21903054/
- American Diabetes Association. Standards of Medical Care in Diabetes 2024: Chronic Kidney Disease and Risk Management. Diabetes Care. 2024;47(Suppl 1):S219-S230. https://diabetesjournals.org/care/article/47/Supplement_1/S219/153946/
- GoodRx. Losartan potassium pricing. 2025. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files
- U.S. Food and Drug Administration. Guidance for Industry: Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act. 2018. https://www.fda.gov/media/107052/download
- Yeo WW, Ramsay LE. Persistent dry cough with enalapril: incidence depends on method used. J Hum Hypertens. 1990;4(5):517-520. https://pubmed.ncbi.nlm.nih.gov/2290516/
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Cholesterol Guideline. Circulation. 2019;139(25):e1082-e1143. https://pubmed.ncbi.nlm.nih.gov/30586774/
- West Virginia Legislature. Senate Bill 272: Advanced Practice Registered Nurse Independence. 2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042001/
- Mehrotra A, Jena AB, Busch AB, Souza J, Uscher-Pines L, Landon BE. Utilization of telemedicine among rural Medicare beneficiaries. JAMA. 2016;315(18):2015-2016. https://pubmed.ncbi.nlm.nih.gov/27163991/
- Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes (ALTITUDE). N Engl J Med. 2012;367(23):2204-2213. https://pubmed.ncbi.nlm.nih.gov/23121378/
- Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure (Val-HeFT). N Engl J Med. 2001;345(23):1667-1675. https://pubmed.ncbi.nlm.nih.gov/11759645/
- Mancia G, Kreutz R, Brunstrom M, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874-2071. https://pubmed.ncbi.nlm.nih.gov/37345492/